Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kaihoujian inhalation versus Kaihoujian oral spray versus budesonide inhalation for acute laryngitis
ChiCTR1900026660Phase 4Recruiting
- Sponsor
- 中国中医科学院望京医院
- Start
- Oct 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of kaihoujian and budesonide in Acute Laryngitis (3 arms), sponsored by 中国中医科学院望京医院. Primary endpoint: Symptoms. Started Oct 2019; status: recruiting.
02
Drugs
kaihoujianbudesonide
03
Conditions
Acute Laryngitis
Beyond the preview
Go deeper on ChiCTR1900026660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026660.